Thrombopoietin production in human hepatic cell cultures (HepG2) is resistant to IFN-alpha, IFN-beta, and IFN-gamma treatment.

No abstract is available for this paper.

• Publication year

  2002

• Venue

  Journal of Interferon and Cytokine Research

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  PMID 12581491
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effects of chemotherapeutic and immunosuppressive drugs on the production of erythropoietin in human hepatoma cultures

  2005cited by this paper
• Thrombopoietin: the novel hepatic hormone.

  2002cited by this paper
• Review: Activities of IRF-1

  2002cited by this paper
• The role of thrombopoietin in post‐operative thrombocytosis

  2001cited by this paper
• Interleukin-6 stimulates thrombopoiesis through thrombopoietin: role in inflammatory thrombocytosis.

  2001cited by this paper
• Effects of anticoagulation on thrombopoietin release during endotoxemia.

  2001cited by this paper
• Hepatic Thrombopoietin mRNA Is Increased in Acute Inflammation

  2001cited by this paper
• Expression of hepatic thrombopoietin mRNA in primary cultured hepatocytes and in rats with acute liver injury or bone marrow suppression with or without cirrhosis

  2000cited by this paper
• Hepatocyte growth factor/scatter factor enhances the thrombopoietin mRNA expression in rat hepatocytes and cirrhotic rat livers

  2000cited by this paper
• Fulminant meningococcal septicemia: dissociation between plasma thrombopoietin levels and platelet counts.

  2000cited by this paper
• A unique ISRE, in the TATA-less human Isg20 promoter, confers IRF-1-mediated responsiveness to both interferon type I and type II.

  2000cited by this paper
• Interleukin-6 Increases Thrombopoietin Production in Human Hepatoma Cells HepG2 and Hep3B

  2000cited by this paper
• Interferon-alpha directly represses megakaryopoiesis by inhibiting thrombopoietin-induced signaling through induction of SOCS-1.

  2000cited by this paper
• Thrombopoietin and liver diseases

  2000cited by this paper
• Circulating thrombopoietin in reactive conditions behaves like an acute phase reactant.

  1999cited by this paper
• Blunted thrombopoietin response to interferon alfa–induced thrombocytopenia during treatment for hepatitis C

  1998influential reference
• Identification of genes differentially regulated by interferon alpha, beta, or gamma using oligonucleotide arrays.

  1998cited by this paper
• Productive human immunodeficiency virus-1 infection of purified megakaryocytic progenitors/precursors and maturing megakaryocytes.

  1998cited by this paper
• Thrombopoietin.

  1998cited by this paper
• Ineffective platelet production in thrombocytopenic human immunodeficiency virus-infected patients.

  1998cited by this paper
• Interferon‐induced thrombocytopenia: Is it time for thrombopoietin?

  1998cited by this paper
• Thrombopoietin‐independent effect of interferon‐γ on the proliferation of human megakaryocyte progenitors

  1997cited by this paper
• Thrombopoietin Levels in Patients with Cirrhosis before and after Orthotopic Liver Transplantation

  1997cited by this paper
• Thrombopoietin: the primary regulator of megakaryocytopoiesis and thrombopoiesis.

  1997cited by this paper
• Human platelets display high-affinity receptors for thrombopoietin.

  1997cited by this paper
• Interferon treatment for hepatitis C virus infection in patients on haemodialysis.

  1997cited by this paper
• Interferon increases serum thrombopoietin in patients with chronic hepatitis C

  1997cited by this paper
• Localization and regulation of thrombopoietin mRNa expression in human kidney, liver, bone marrow, and spleen using in situ hybridization.

  1997cited by this paper
• Regulation of thrombopoietin levels by c-mpl-mediated binding to platelets.

  1996cited by this paper
• Constitutive expression of the thrombopoietin gene in a human hepatoma cell line.

  1995cited by this paper
• A laboratory and thrombokinetic study of HCV-associated thrombocytopenia: a direct role of HCV in bone marrow exhaustion?

  1995cited by this paper
• Antibody-enhanced binding of dengue-2 virus to human platelets.

  1995cited by this paper
• Murine thrombopoietin mRNA levels are modulated by platelet count.

  1995cited by this paper
• Both type I and type II interferons down‐regulate human tumor necrosis factor receptors in human hepatocellular carcinoma cell line Hep G2

  1994cited by this paper
• The signalling pathways of interleukin-6 and gamma interferon converge by the activation of different transcription factors which bind to common responsive DNA elements

  1994cited by this paper
• A controlled trial of interferon gamma to prevent infection in chronic granulomatous disease. The International Chronic Granulomatous Disease Cooperative Study Group.

  1991cited by this paper
• The regulated expression of erythropoietin by two human hepatoma cell lines.

  1987cited by this paper
• Interaction of influenza virus with blood platelets.

  1966cited by this paper

• Thrombopoietin Contributes to Enhanced Platelet Activation in Patients with Type 1 Diabetes Mellitus

  2021cites this paper
• Quantitative systems pharmacology of interferon alpha administration: A multi-scale approach

  2019cites this paper
• Snake-Bite with Disseminated Intravascular Coagulation (DIC) and Stage II Hypertension

  2017cites this paper
• Use of thrombopoietic agents for the thrombocytopenia of liver disease.

  2010cites this paper
• Role of growth factors and thrombopoietic agents in the treatment of chronic hepatitis C

  2009cites this paper
• High Thrombopoietin Concentrations in The Cerebrospinal Fluid of Neonates with Sepsis And Intraventricular Hemorrhage May Contribute to Brain Damage

  2007cites this paper
• Thrombopoietin Production in Wild-Type and Interleukin-6 Knockout Mice with Acute Inflammation

  2005cites this paper